Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recruiting patients to a digital self-management study whilst in hospital for a chronic obstructive pulmonary disease exacerbation: A feasibility analysis.
Whelan M, Biggs C, Areia C, King E, Lawson B, Newhouse N, Ding X, Velardo C, Bafadhel M, Tarassenko L, Watkinson P, Clifton D, Farmer A. Whelan M, et al. Among authors: bafadhel m. Digit Health. 2021 May 27;7:20552076211020876. doi: 10.1177/20552076211020876. eCollection 2021 Jan-Dec. Digit Health. 2021. PMID: 34104470 Free PMC article.
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.
Bafadhel M, Rabe KF, Martinez FJ, Singh D, Darken P, Jenkins M, Aurivillius M, Patel M, Dorinsky P. Bafadhel M, et al. Int J Chron Obstruct Pulmon Dis. 2022 Dec 6;17:3061-3073. doi: 10.2147/COPD.S374670. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36510486 Free PMC article. Clinical Trial.
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
Brightling CE, Bleecker ER, Panettieri RA Jr, Bafadhel M, She D, Ward CK, Xu X, Birrell C, van der Merwe R. Brightling CE, et al. Among authors: bafadhel m. Lancet Respir Med. 2014 Nov;2(11):891-901. doi: 10.1016/S2213-2600(14)70187-0. Epub 2014 Sep 7. Lancet Respir Med. 2014. PMID: 25208464 Free PMC article. Clinical Trial.
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
Ghebre MA, Pang PH, Diver S, Desai D, Bafadhel M, Haldar K, Kebadze T, Cohen S, Newbold P, Rapley L, Woods J, Rugman P, Pavord ID, Johnston SL, Barer M, May RD, Brightling CE. Ghebre MA, et al. Among authors: bafadhel m. J Allergy Clin Immunol. 2018 Jun;141(6):2027-2036.e12. doi: 10.1016/j.jaci.2018.04.013. Epub 2018 Apr 28. J Allergy Clin Immunol. 2018. PMID: 29709671 Free PMC article.
Chronic obstructive pulmonary disease.
Christenson SA, Smith BM, Bafadhel M, Putcha N. Christenson SA, et al. Among authors: bafadhel m. Lancet. 2022 Jun 11;399(10342):2227-2242. doi: 10.1016/S0140-6736(22)00470-6. Epub 2022 May 6. Lancet. 2022. PMID: 35533707 Review.
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.
Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group. Jones RC, et al. Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13. Lancet Respir Med. 2014. PMID: 24717623 Free article.
Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.
Barker BL, McKenna S, Mistry V, Pancholi M, Patel H, Haldar K, Barer MR, Pavord ID, Steiner MC, Brightling CE, Bafadhel M. Barker BL, et al. Among authors: bafadhel m. Int J Chron Obstruct Pulmon Dis. 2014 Sep 15;9:975-81. doi: 10.2147/COPD.S63568. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 25246784 Free PMC article.
122 results